Complete response and long-term survival after short-course camrelizumab plus apatinib, hepatic arterial infusion chemotherapy, and transarterial chemoembolization in large and advanced hepatocellular carcinoma: a case report.
Saved in:
| Title: | Complete response and long-term survival after short-course camrelizumab plus apatinib, hepatic arterial infusion chemotherapy, and transarterial chemoembolization in large and advanced hepatocellular carcinoma: a case report. |
|---|---|
| Authors: | Qiao JH; Department of Interventional Therapy, Liaoning Cancer Hospital & Institute, Shenyang, China., Wang Y; Department of Interventional Therapy, Liaoning Cancer Hospital & Institute, Shenyang, China., Fu CX; Department of Interventional Therapy, Liaoning Cancer Hospital & Institute, Shenyang, China., Yang JD; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Takemura N; Department of Hepato-Biliary-Pancreatic Surgery and Pediatric Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan., Zheng WH; Department of Interventional Therapy, Liaoning Cancer Hospital & Institute, Shenyang, China. |
| Source: | Journal of gastrointestinal oncology [J Gastrointest Oncol] 2024 Oct 31; Vol. 15 (5), pp. 2323-2329. Date of Electronic Publication: 2024 Oct 14. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: AME Publishing Group Country of Publication: China NLM ID: 101557751 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2078-6891 (Print) Linking ISSN: 20786891 NLM ISO Abbreviation: J Gastrointest Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2078-6891 |
|---|---|
| DOI: | 10.21037/jgo-24-613 |
